IMI llançarà a finals de 2013 la seva 11ª convocatòria. Els temes que cobreix són:

- Applied public-private research enabling osteoarthritis clinical headway (APPROACH)
- European platform for proof of concept for prevention in Alzheimer’s Disease (EPOC-AD)
- Blood-based biomarker assays for personalized tumour therapy: value of latest circulating biomarkers
- Zoonoses anticipation and preparedness initiative (ZAPI).
- Generation of research tools to translate genomic discoveries into drug discovery projects
- Ecorisk prediction (ERP)
Dincs el tema New Drugs for Bad Bugs (ND4BB), es cobriran els següents aspectes:
- ND4BB Topic 6: Epidemiology research and development of novel systemic antibacterial molecules against healthcare-associated infections due to gram-negative pathogens
- ND4BB Topic 7: Development of novel inhaled antibiotic regimens in patients with cystic fibrosis (CF) and patients with non-CF bronchiectasis (BE)

Tingueu en compte que aquesta informació pot patir modificacions. Podeu trobar el text provisional de la convocatòria al lloc web d'IMI.